CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Phreesia›
Products & Services›
Appointment Scheduling
Appointment Scheduling

Phreesia› offers Appointment Scheduling

ProductOperating Status: Currently Offered

Phreesia Appointment Scheduling is an AI-powered patient scheduling platform that reduces no-shows and fills cancellations.

Loading
Overview

Phreesia Appointment Scheduling is an AI-powered scheduling platform that lets patients book appointments 24/7 and automatically fills cancellations to reduce no-shows. Automated reminders via text and email help patients remember, confirm, or reschedule before they become no-shows.

The platform handles every appointment type, routes each booking to the right provider, and connects scheduling with registration, payments, and communication through two-way EHR integrations.

Appointment Scheduling - Classification

Industry
  • Healthcare SaaS
Technology
  • AI
Model
  • Platform
Revenue
  • Recurring
Customer
  • Healthcare Providers
Tags
  • Healthtech

More from Phreesia

  • Phreesia Patient Intake Platform logo

    Phreesia Patient Intake Platform

Appointment Scheduling - Direct Competitors

  • Demandforce

    Demandforce logo

    Patient Communication Software

    demandforce.com

  • DocSpera

    DocSpera logo

    Patient Readiness

    docspera.com

AttributeAppointment SchedulingPatient Communication SoftwarePatient Readiness
ProviderPhreesiaphreesia.com$112.6M raised · PublicDemandforcedemandforce.com$423.5M raisedDocSperadocspera.com$10M raised · Series B
Founded200520032014
Sells ToEnterpriseSmall and Medium BusinessesEnterprise
Pricing ModelRecurring, SoftwareSubscriptionRecurring, Software, Transactional
OwnershipPublicAcquired SubsidiaryPrivate, Venture Capital
Appointment Scheduling

Provider Phreesiaphreesia.com$112.6M raised · Public

Founded 2005

Sells To Enterprise

Pricing Model Recurring, Software

Ownership Public

Patient Communication Software

Provider Demandforcedemandforce.com$423.5M raised

Founded 2003

Sells To Small and Medium Businesses

Pricing Model Subscription

Ownership Acquired Subsidiary

Patient Readiness

Provider DocSperadocspera.com$10M raised · Series B

Founded 2014

Sells To Enterprise

Pricing Model Recurring, Software, Transactional

Ownership Private, Venture Capital

Appointment Scheduling - Similar Products & Services

  • Primary Care logo

    Primary Care

  • AS

    Appointment Scheduling Platform

  • AI Patient Engagement logo

    AI Patient Engagement

    docspera.com

  • Parakeet Health Patient Access Platform logo

    Parakeet Health Patient Access Platform

    parakeethealth.com

  • HealthAI logo

    HealthAI

    eliseai.com

  • Collate ClinicOS logo

    Collate ClinicOS

  • GoMeddo Scheduling Platform logo

    GoMeddo Scheduling Platform

  • Appointiv Scheduling logo

    Appointiv Scheduling

  • Smart Scheduling logo

    Smart Scheduling

    docspera.com

  • Arini AI Receptionist logo

    Arini AI Receptionist

    arini.ai

  • Microsoft Bookings logo

    Microsoft Bookings

    microsoft.com

  • AI Voice Agent Platform for Healthcare logo

    AI Voice Agent Platform for Healthcare

  • Calendly Scheduling logo

    Calendly Scheduling

    calendly.com